Human cells for human proteins: Isotope labeling in mammalian cells in suspension for functional NMR studies
Protein Science · 2026
DOI: 10.1002/pro.70515 ↗At a glance
Journal article in Protein Science, 2026. Written by Philip Rößler and 11 co-authors. Institution: Department of Biology, ETH Zürich, Zürich, Switzerland. Major MEDLINE topics: Isotope Labeling, Nuclear Magnetic Resonance, Biomolecular, Proteins. Cited 2 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY 4.0). Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (original language)
In biological and biomedical research, the focus progressively moves towards difficult human proteins, which often can only be expressed in higher eukaryotic cells. Nuclear magnetic resonance (NMR) could contribute significantly to the understanding of important proteins as it is one of the most information‐rich methods. However, to exploit the full potential of NMR, proteins must be isotope labeled. Although expression protocols in, for example, HEK293 cells are often established, isotope labeling is difficult and very expensive, and published protocols are mostly limited to adherent cells in plates. To resolve this disparity, we have developed a comprehensive suite of protocols for isotope labeling in HEK293 cells in suspension. We demonstrate uniform 15 N and 13 C labeling, as well as specific labeling, with special focus on methyl bearing amino acids, including the popular ILV 13 C‐methyl labeling pattern. In addition, several innovative practices are introduced to deal with special cases. Labeling is achieved with a simple laboratory setup and affordable labeling media. These are based on either labeled amino acids, their precursors or amino extracts from microorganisms, like yeast, algae or bacteria. We demonstrate how these protocols enable NMR studies of proteins that are considered to be especially difficult to produce, for example, different human membrane proteins and nuclear receptors. We therefore expect that these new methods make many highly important proteins accessible to NMR studies and allow exploiting the high information content of this method for accelerating biological and pharmaceutical research.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biology, ETH Zürich, Zürich, Switzerland.
- Paul Scherrer Institute, Villigen, Switzerland.
- Institute of Organic Chemistry, University of Vienna, Vienna, Austria.
- MagLab, Vienna, Austria.
- Novartis Institutes for BioMedical Research, Basel, Switzerland.
- Department of Structural and Computational Biology, University of Vienna, Vienna, Austria.
ORCID profiles: Philip Rößler, Marco M Ruckstuhl, Timo Stühlinger, Ching-Ju Tsai, Roman Lichtenecker, Simon H Rüdisser, Robert Konrat, Gebhard F X Schertler, Alvar D Gossert
Funding
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Cite
APA
Rößler, P., Ruckstuhl, M. M., Löbbert, A., Stühlinger, T., Franchini, L. R., Tsai, C. J., Lichtenecker, R., Shrestha, B., Rüdisser, S. H., Konrat, R., Schertler, G. F. X., & Gossert, A. D. (2026). Human cells for human proteins: Isotope labeling in mammalian cells in suspension for functional NMR studies. Protein Science. https://doi.org/10.1002/pro.70515
Vancouver
Rößler P, Ruckstuhl MM, Löbbert A, Stühlinger T, Franchini LR, Tsai CJ, et al. Human cells for human proteins: Isotope labeling in mammalian cells in suspension for functional NMR studies. Protein Science. 2026. doi:10.1002/pro.70515
BibTeX
@article{Rler2026,
author = {Rößler, Philip and Ruckstuhl, Marco M and Löbbert, Arnelle and Stühlinger, Timo and Franchini, Lucia R and Tsai, Ching-Ju and Lichtenecker, Roman and Shrestha, Binesh and Rüdisser, Simon H and Konrat, Robert and Schertler, Gebhard F X and Gossert, Alvar D},
title = {Human cells for human proteins: Isotope labeling in mammalian cells in suspension for functional NMR studies},
journal = {Protein Science},
year = {2026},
doi = {10.1002/pro.70515}
}
EUVIMED